OncoSec Medical Inc (ONCSQ)

[chickpea598]

Also one other thing to note here is that 9 patients is a very small set of patients to gauge by so 1 more responder here is the difference between 33% and 44% so if you applied that number to say 1000 people if the percentages hold up in a larger trial of non-responders you are talking about a lot of people who now have a second chance with combo therapy. 300 or 400 people for every 1000 people suffering melanoma cancer could be treated. I think the markets are easily disappointed and expecting a grand slam home run. Oncosec is on the right track though in my opinion.